These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33281164)

  • 21. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.
    N'Kontchou G; Seror O; Bourcier V; Mohand D; Ajavon Y; Castera L; Grando-Lemaire V; Ganne-Carrie N; Sellier N; Trinchet JC; Beaugrand M
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):179-84. PubMed ID: 15674095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.
    Foruny JR; Blázquez J; Moreno A; Bárcena R; Gil-Grande L; Quereda C; Pérez-Elías MJ; Moreno J; Sánchez J; Muriel A; Rodriguez-Sagrado MA; Moreno S
    Eur J Gastroenterol Hepatol; 2005 Nov; 17(11):1157-64. PubMed ID: 16215426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
    Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
    Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Splenic embolization and hepatic chemoembolization: combined transcatheter treatment of hepatocellular carcinoma in cirrhosis with hypersplenism].
    Roversi R; Ricci S; Gambari PI; Castaldini L; Rossi G; Milandri G; Formica G; Dalmonte PR
    Radiol Med; 1993 Apr; 85(4):444-9. PubMed ID: 8390705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.
    Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Ishiko T; Baba H
    J Gastroenterol; 2010 May; 45(5):554-9. PubMed ID: 20047119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin.
    Moreno A; Bárcena R; Blázquez J; Quereda C; Gil-Grande L; Sánchez J; Moreno L; Perez-Elías MJ; Antela A; Moreno J; del Campo S; Moreno S
    Antivir Ther; 2004 Dec; 9(6):1027-30. PubMed ID: 15651761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic arterial buffer response in patients with advanced cirrhosis.
    Gülberg V; Haag K; Rössle M; Gerbes AL
    Hepatology; 2002 Mar; 35(3):630-4. PubMed ID: 11870377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and clinical course of portal and/or splenic vein thrombosis after partial splenic embolization.
    Matsumoto T; Yamagami T; Terayama K; Kato T; Hirota T; Yoshimatsu R; Miura H; Ito H; Okanoue T; Nishimura T
    Acta Radiol; 2009 Jul; 50(6):617-23. PubMed ID: 19449229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension.
    Saeki M; Okubo H; Takasaki Y; Nakadera E; Fukuo Y; Fukada H; Hotchi Y; Maruyama H; Kokubu S; Shiina S; Nagahara A; Ikejima K
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial splenic embolization of patients with hypersplenism by transradial or transfemoral approach: a prospective randomized controlled trial.
    Wu T; Sun R; Huang Y; Wang Z; He J; Shen S; Yin X; Zhu Z; Yang W; Zhao Z
    Acta Radiol; 2016 Oct; 57(10):1201-4. PubMed ID: 26671306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
    Jácome AA; Ohinata A; Mahvash A; Overman MJ; Kee B; Fogelman D; Morris VK; Johnson B; Rothschild ND; Wolff RA; Eng C
    Clin Colorectal Cancer; 2020 Dec; 19(4):e189-e199. PubMed ID: 32680816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative assessment of hepatic and splenic blood flow status in patients with hypersplenism of different degrees based on multi-slice spiral CT whole-liver perfusion imaging].
    Gao YJ; Gao ZL; Sun WJ; Qiu HJ; Deng L; Ren T; Yang GH; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2020 Apr; 28(4):326-331. PubMed ID: 32403885
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical application of kelp micro gelation (KMG) in partial splenic embolization.
    Huang DJ; Huang JZ; Yang Y; Luo YC; He HY; Song WL; Li YH
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1776-1781. PubMed ID: 29630126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous CSM-TACE with CalliSpheres
    Zhou J; Feng Z; Liu S; Li X; Liu Y; Gao F; Shen J; Zhang YW; Zhao GS; Zhang M
    Front Oncol; 2022; 12():998500. PubMed ID: 36530976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of percutaneous transhepatic variceal embolization (PTVE) followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage.
    Duan X; Zhang K; Han X; Ren J; Xu M; Huang G; Zhang M
    J Vasc Interv Radiol; 2014 Dec; 25(12):1858-65. PubMed ID: 25311969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.
    Lee CM; Leung TK; Wang HJ; Lee WH; Shen LK; Liu JD; Chang CC; Chen YY
    World J Gastroenterol; 2007 Jan; 13(4):619-22. PubMed ID: 17278231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis of residual spleen after partial splenic embolization for the treatment of hypersplenism in cirrhosis].
    Iida T; Sakino I; Akagi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Mar; 58(4):152-6. PubMed ID: 9584459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism: does increased hepatic arterial flow induce liver regeneration?
    Liu Q; Ma K; Song Y; Zhou N; He Z
    Surgery; 2008 Apr; 143(4):509-18. PubMed ID: 18374048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis].
    Nomiyama K; Akagi K; Watanabe H; Kajiwara E; Sakino I
    Fukuoka Igaku Zasshi; 1991 Mar; 82(3):105-9. PubMed ID: 2066049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.